Led by OMRF scientist Charles Esmon, Ph.D., TACTIC brings together leaders in the field to study coagulopathy, a deadly bleeding syndrome resulting from traumatic injury. The TACTIC study is a cooperative effort funded by the National Heart, Lung and Blood Institute that establishes a unique collaboration between the National Institutes of Health and the Department of Defense. This unique initiative integrates laboratory, clinical and early translational, hypothesis-driven research by leading investigators across the country and enables the basic science investigative units to explore clinical specimens obtained from the DoD centers.
Additional institutions involved in the research funded by the TACTIC grant include Massachusetts Institute of Technology, Mayo Clinic, Scripps Research Institute, University of California-San Francisco, University of Illinois and University of Pennsylvania. DoD-supported institutions participating in the clinical component of the TACTIC grant include University of Colorado, University of Pittsburgh, and Virginia Commonwealth University.